(Q40624607)

22 September 2017

title

IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host (English)

1 reference

22 September 2017

IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

23 March 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

23 March 2024

author

Germain J.P. Fernando

6

object named as

Germain J. P. Fernando

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568953

23 March 2024

author name string

Xiao Song Liu

1

1 reference

22 September 2017

Yan Xu

2

1 reference

22 September 2017

Lani Hardy

3

1 reference

22 September 2017

Vithagna Khammanivong

4

1 reference

22 September 2017

Weiming Zhao

5

1 reference

22 September 2017

Graham R. Leggatt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568953

23 March 2024

Ian H. Frazer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568953

23 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

22 September 2017

published in

Journal of Immunology

1 reference

22 September 2017

volume

171

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

4765-4772

1 reference

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

22 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830230929

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

23 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

23 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

A controlled trial of a human papillomavirus type 16 vaccine

23 March 2024

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

23 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

23 March 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

23 March 2024

15

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.

23 March 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

The serological response to papillomaviruses

23 March 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

23 March 2024

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion

23 March 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion

23 March 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay

23 March 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

23 March 2024

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein

23 March 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses

23 March 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

The evolution of MHC diversity by segmental duplication and transposition of retroelements.

23 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

HPV6b virus like particles are potent immunogens without adjuvant in man.

23 March 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins

23 March 2024

31

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers

23 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Disquisitions of Original Antigenic Sin. I. Evidence in man

23 March 2024

33

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Molecular analysis of original antigenic sin. I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response

23 March 2024

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

23 March 2024

38

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Facing two T cell epitopes: a degree of randomness in the primary response is lost upon secondary immunization.

23 March 2024

40

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

23 March 2024

42

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

T cells compete for access to antigen-bearing antigen-presenting cells

23 March 2024

43

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

B cells solicit their own help from T cells.

23 March 2024

45

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

T-regulatory cells: are we re-discovering T suppressors?

23 March 2024

46

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

23 March 2024

47

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Interleukin-10 and the interleukin-10 receptor

23 March 2024

48

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses

23 March 2024

49

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR.

23 March 2024

50

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term

23 March 2024

51

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4765

23 March 2024

Identifiers

1 reference

22 September 2017

1 reference